Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of Metabolomics in Drug Resistant Breast Cancer Research
Ayesha N. Shajahan‐Haq, Mehar Cheema, Robert Clarke
Metabolites (2015) Vol. 5, Iss. 1, pp. 100-118
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Livestock metabolomics and the livestock metabolome: A systematic review
Seyed Ali Goldansaz, An Chi Guo, Tanvir Sajed, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0177675-e0177675
Open Access | Times Cited: 290
Translational Metabolomics: Current Challenges and Future Opportunities
Farhana R. Pinu, Seyed Ali Goldansaz, Jacob Jaine
Metabolites (2019) Vol. 9, Iss. 6, pp. 108-108
Open Access | Times Cited: 170
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Lyudmila V. Bel’skaya, Elena I. Dyachenko
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4646-4687
Open Access | Times Cited: 11
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
Marco Fiorillo, Federica Sotgia, Diego Sisci, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 20309-20327
Open Access | Times Cited: 70
Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer
Samarth Kansara, Vijay Pandey, Peter E. Lobie, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 69
Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.
Mojtaba Ghasemi, Iraj Nabipour, Abdolmajid Omrani, et al.
PubMed (2016) Vol. 6, Iss. 6, pp. 310-327
Closed Access | Times Cited: 66
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
Krishan Kumar Thakur, Aviral Kumar, Kishore Banik, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 12, pp. 7938-7965
Closed Access | Times Cited: 50
The evolving landscape of untargeted metabolomics
Alessandro Di Minno, Monica Gelzo, Mariano Stornaiuolo, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 6, pp. 1645-1652
Closed Access | Times Cited: 47
The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer
Samarth Kansara, Agrata Singh, Abhishesh Kumar Badal, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 1-12
Closed Access | Times Cited: 17
Deciphering metabolic rewiring in breast cancer subtypes
Martin P. Ogrodzinski, Jamie J. Bernard, Sophia Y. Lunt
Translational research (2017) Vol. 189, pp. 105-122
Closed Access | Times Cited: 56
Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women
Mónica P. Cala, Julian Aldana, Jéssica Medina, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0190958-e0190958
Open Access | Times Cited: 55
Ophiopogonin D inhibits cell proliferation, causes cell cycle arrest at G2/M, and induces apoptosis in human breast carcinoma MCF-7 cells
Qing-qing Zang, Lu Zhang, Ning Gao, et al.
Journal of Integrative Medicine (2016) Vol. 14, Iss. 1, pp. 51-59
Closed Access | Times Cited: 46
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
Chunyu Liu, Chia‐Yun Wu, Karineh Petrossian, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2017) Vol. 172, pp. 166-175
Closed Access | Times Cited: 44
Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1 H HR-MAS NMR spectroscopy
Roberta M. Maria, Wanessa Fernanda Altei, Heloísa Sobreiro Selistre-de-Araújo, et al.
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 146, pp. 324-328
Open Access | Times Cited: 44
The metabolomics and lipidomics window into thyroid cancer research
Reyhaneh Farrokhi Yekta, Mostafa Rezaei‐Tavirani, Afsaneh Arefi Oskouie, et al.
Biomarkers (2016), pp. 1-9
Closed Access | Times Cited: 41
Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health
Vladimir Tolstikov
Metabolites (2016) Vol. 6, Iss. 3, pp. 20-20
Open Access | Times Cited: 40
A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
Marcella R. Cardoso, Juliana C. Santos, Marcelo Lima Ribeiro, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 617-617
Open Access | Times Cited: 40
Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level
Nan Zhang, Ming Gao, Zihan Wang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 201, pp. 114129-114129
Closed Access | Times Cited: 32
Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
Ajay Kumar Pal, Prateek Sharma, Alishan Zia, et al.
Pathophysiology (2022) Vol. 29, Iss. 2, pp. 200-222
Open Access | Times Cited: 19
When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective
Zhiqiang Zhang, Chaohui Bao, Jiang Lu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 12
Monolayer LDH Nanosheets with Ultrahigh ICG Loading for Phototherapy and Ca2+-Induced Mitochondrial Membrane Potential Damage to Co-Enhance Cancer Immunotherapy
Bengao Zhu, Fei Qu, Duohang Bi, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 7, pp. 9135-9149
Closed Access | Times Cited: 12
The Interplay between Microbiota and Chemotherapy-Derived Metabolites in Breast Cancer
Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado
Metabolites (2023) Vol. 13, Iss. 6, pp. 703-703
Open Access | Times Cited: 11
Metabolomics insights into doxorubicin and 5-fluorouracil combination therapy in triple-negative breast cancer: a xenograft mouse model study
Mohamed Y. Hassanein, Yousra A. Hagyousif, Ruba A. Zenati, et al.
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access
Endocrinology Meets Metabolomics: Achievements, Pitfalls, and Challenges
Janina Tokarz, Mark Haid, Alexander Cecil, et al.
Trends in Endocrinology and Metabolism (2017) Vol. 28, Iss. 10, pp. 705-721
Closed Access | Times Cited: 36
Integrated Network Pharmacology and Metabolomics Analysis of the Therapeutic Effects of Zi Dian Fang on Immune Thrombocytopenic Purpura
Yubo Li, Yamei Li, Wenliang Lu, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top